Regal Rexnord (RRX) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
8 Jul, 2026Executive summary
Net sales for Q3 2025 increased 1.3% year-over-year to $1,497.0 million, with organic sales up 0.7% and positive foreign currency impact, partially offset by divestitures.
Adjusted diluted EPS was $2.51, up 0.8% year-over-year; GAAP diluted EPS was $1.20, up 10.1% year-over-year.
Data center orders totaled $135 million in Q3, with an additional $60 million in October, driving order momentum and a bid pipeline approaching $1 billion.
Cash from operating activities was $197.5 million in Q3, with adjusted free cash flow at $174 million.
Paid down $74.5 million in gross debt, ending the quarter with no variable rate debt and net debt/adjusted EBITDA (including synergies) at ~3.2x.
Financial highlights
Q3 2025 gross profit was $554.2 million (37.0% of net sales), with adjusted gross margin at 37.6%.
Adjusted EBITDA was $339.4 million, with a margin of 22.7%.
Adjusted diluted EPS was $2.51, compared to $2.49 in the prior year.
Adjusted free cash flow for Q3 was $174 million, up from $125.5 million year-over-year.
Cash and cash equivalents at quarter-end were $400.0 million.
Outlook and guidance
Annual GAAP diluted EPS guidance narrowed and lowered to $4.26–$4.56; adjusted diluted EPS guidance to $9.50–$9.80, reflecting unfavorable tariff and China trade policy impacts.
Sales guidance for 2025 raised modestly to $5.96 billion, with low single-digit organic growth expected.
Free cash flow for 2025 expected at ~$625 million; 2026 projected at nearly $900 million.
Margin neutrality on tariffs anticipated by end of 2026, with cost neutrality by mid-2026.
Projecting mid-single digit organic growth in Q4 and low- to mid-single digit growth in 2026.
Latest events from Regal Rexnord
- Net income nearly doubled in Q2 2024 as synergy capture and debt reduction accelerated.RRX
Q2 20248 Jul 2026 - Organic sales up 0.7%, margins and EPS rose, and 2025 guidance is reaffirmed.RRX
Q1 20258 Jul 2026 - Targets 2%-5% organic growth, ~40% gross margins, and $1B+ free cash flow by 2027.RRX
Investor Day 20248 Jul 2026 - Integrated solutions and data center growth drive margin gains and future capital flexibility.RRX
Oppenheimer 21st Annual Industrial Growth Virtual Conference8 May 2026 - Sales up 4.3% to $1.48B, orders strong, 2026 outlook raised, CEO transition in progress.RRX
Q1 20267 May 2026 - Data center and automation growth drive outlook, with margin gains from lean and mix shift.RRX
Barclays 43rd Annual Industrial Select Conference10 Apr 2026 - Strong growth, margin expansion, and secular market exposure drive robust 2027 outlook.RRX
Investor presentation18 Mar 2026 - Proxy covers director elections, CEO transition, pay-for-performance, and major ESG progress.RRX
Proxy Filing18 Mar 2026 - Board recommends approval of all proposals at the April 2026 annual meeting.RRX
Proxy Filing18 Mar 2026